---
title: "TX5 photosensitizer targets mitochondrial DNA G-quadruplexes to bypass cisplatin resistance in lun"
id: "pubmed-42933202"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42933202"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42933202/"
doi: "10.1016/j.bioorg.2026.110694"
published_at: "2026-11-15T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# TX5 photosensitizer targets mitochondrial DNA G-quadruplexes to bypass cisplatin resistance in lun
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42933202
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42933202/)
- **DOI:** [10.1016/j.bioorg.2026.110694](https://doi.org/10.1016%2Fj.bioorg.2026.110694)
- **Published At:** 2026-11-15T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Investigators synthesized a tetrahydroxanthylium-thiophene-triphenylamine photosensitizer named **TX5** designed to target **mitochondrial DNA G-quadruplex** structures. - The molecule's unhindered tetrahydroxanthylium core reduced steric tension, which the authors reported improved binding affinity and selectivity for a specific mtDNA G4 sequence. - In the cisplatin-resistant A549/DDP lung cancer cell line, the compound localized to mitochondria and enabled target-activated near-infrared fluorescence imaging. - Under white light irradiation, **TX5** produced hydroxyl radicals, producing oxidative stress within mitochondria. - Oxidative damage disrupted mitochondrial bioenergetics, lowered ATP, and reduced mitochondrial membrane potential, according to the study team. - Those mitochondrial perturbations triggered G2/M cell cycle arrest and activated the intrinsic apoptotic pathway via Caspase-9 and Caspase-3. - Functionally, investigators observed inhibition of cell migration and suppression of growth in 3D multicellular tumor spheroids. - Authors framed the approach as an organelle-targeted **photodynamic therapy** strategy intended to bypass nuclear DNA repair–mediated cisplatin resistance. - The abstract does not report in vivo efficacy, specific dosing regimens, irradiation parameters, safety or toxicity data, nor regulatory milestones.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42933202/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42933202%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42933202/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42933202/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42933202/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42933202/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42933202/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42933202%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42933202%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42933202/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42933202/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42933202/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42933202/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Elsevier Science full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--linkinghub.elsevier.com-ihub-images-PubMedLink.gif) Elsevier Science ](https://linkinghub.elsevier.com/retrieve/pii/S0045-2068\(26\)01230-7 "See full text options at Elsevier Science") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42933202/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42933202/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42933202/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42933202/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42933202/#conflict-of-interest) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42933202/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42933202/#substances) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42933202/#linkout) Title & authors Abstract Conflict of interest statement MeSH terms Substances LinkOut - more resources Bioorg Chem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Bioorg+Chem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Bioorg+Chem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) . 2026 Nov 15:184:110694. doi: 10.1016/j.bioorg.2026.110694. Epub 2026 Oct 25. # A tetrahydroxanthylium-thiophene-triphenylamine based photosensitizer targeting mitochondrial DNA G-quadruplexes for overcoming cisplatin-resistant lung Cancer via white light photodynamic therapy [Gan Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+G&cauthor_id=42933202)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42933202/#full-view-affiliation-1 "Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China."), [Ming-Hao Hu](https://pubmed.ncbi.nlm.nih.gov/?term=Hu+MH&cauthor_id=42933202)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42933202/#full-view-affiliation-2 "Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. Electronic address: humhao1229@szu.edu.cn.") Affiliations Expand ### Affiliations * 1 Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. * 2 Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. Electronic address: humhao1229@szu.edu.cn. * PMID: **42933202** * DOI: [ 10.1016/j.bioorg.2026.110694 ](https://doi.org/10.1016/j.bioorg.2026.110694) Item in Clipboard # A tetrahydroxanthylium-thiophene-triphenylamine based photosensitizer targeting mitochondrial DNA G-quadruplexes for overcoming cisplatin-resistant lung Cancer via white light photodynamic therapy Gan Li et al. Bioorg Chem. 2026. Show details Display options Display options Format Abstract PubMed PMID Bioorg Chem Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Bioorg+Chem%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Bioorg+Chem%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) . 2026 Nov 15:184:110694. doi: 10.1016/j.bioorg.2026.110694. Epub 2026 Oct 25. ### Authors [Gan Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+G&cauthor_id=42933202)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42933202/#short-view-affiliation-1 "Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China."), [Ming-Hao Hu](https://pubmed.ncbi.nlm.nih.gov/?term=Hu+MH&cauthor_id=42933202)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42933202/#short-view-affiliation-2 "Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. Electronic address: humhao1229@szu.edu.cn.") ### Affiliations * 1 Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. * 2 Nation-Regional Engineering Lab for Synthetic Biology of Medicine, International Cancer Center, School of Pharmacy, Shenzhen University Medical School, Shenzhen, 518060, China. Electronic address: humhao1229@szu.edu.cn. * PMID: **42933202** * DOI: [ 10.1016/j.bioorg.2026.110694 ](https://doi.org/10.1016/j.bioorg.2026.110694) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract The development of multidrug resistance, particularly to frontline agents like cisplatin, limits the clinical efficacy of lung cancer treatments. To circumvent the nuclear DNA repair mechanisms associated with resistance, we developed an organelle-targeted photodynamic therapy (PDT) strategy. Herein, we designed and synthesized a tetrahydroxanthylium-thiophene-triphenylamine-based photosensitizer, TX5, to target mitochondrial DNA G-quadruplexes (mtDNA G4s). The unhindered tetrahydroxanthylium core in TX5 minimized steric tension, resulting in favorable binding affinity and structural selectivity for the mtDNA G4 sequence. In the cisplatin-resistant A549/DDP lung cancer cell line, TX5 localized to mitochondria and enabled target-activated near-infrared fluorescence imaging. Upon white light irradiation, TX5 generated hydroxyl radicals. This induced oxidative stress disrupted mitochondrial bioenergetics, decreased ATP levels, and reduced the mitochondrial membrane potential. Consequently, TX5 bypassed traditional resistance pathways by inducing G2/M cell cycle arrest and activating the Caspase-9/3-dependent intrinsic apoptotic cascade. Furthermore, TX5 inhibited cell migration and suppressed the growth of 3D multicellular tumor spheroids. This study provides a viable molecular engineering approach, suggesting that G4-targeted mitochondrial PDT could serve as a potential strategy for addressing cisplatin resistance. **Keywords:** Cisplatin resistance; Lung Cancer; Mitochondrial DNA G-quadruplex; Photodynamic therapy. Copyright © 2026 Elsevier Inc. All rights reserved. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ## MeSH terms * Antineoplastic Agents* / chemical synthesis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Agents%2Fchemical+synthesis%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Antineoplastic Agents* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Agents%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Antineoplastic Agents* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Agents%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Apoptosis / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Apoptosis%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Apoptosis) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Cell Proliferation / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cell+Proliferation%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cell+Proliferation) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Cisplatin / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cisplatin%2Fpharmacology%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cisplatin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * DNA, Mitochondrial* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22DNA%2C+Mitochondrial%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=DNA%2C+Mitochondrial) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Dose-Response Relationship, Drug Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Dose-Response+Relationship%2C+Drug%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Dose-Response+Relationship%2C+Drug) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Drug Resistance, Neoplasm / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drug+Resistance%2C+Neoplasm%2Fdrug+effects%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drug+Resistance%2C+Neoplasm) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Drug Screening Assays, Antitumor Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Drug+Screening+Assays%2C+Antitumor%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Drug+Screening+Assays%2C+Antitumor) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * G-Quadruplexes* / drug effects Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22G-Quadruplexes%2Fdrug+effects%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=G-Quadruplexes) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Light Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Light%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Light) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Lung Neoplasms* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Lung Neoplasms* / metabolism Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fmetabolism%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Lung Neoplasms* / pathology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fpathology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Molecular Structure Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Molecular+Structure%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Molecular+Structure) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Photochemotherapy* Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Photochemotherapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Photochemotherapy) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Photosensitizing Agents* / chemical synthesis Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Photosensitizing+Agents%2Fchemical+synthesis%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Photosensitizing+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Photosensitizing Agents* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Photosensitizing+Agents%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Photosensitizing+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Photosensitizing Agents* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Photosensitizing+Agents%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Photosensitizing+Agents) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Structure-Activity Relationship Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Structure-Activity+Relationship%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Structure-Activity+Relationship) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Thiophenes* / chemistry Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Thiophenes%2Fchemistry%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Thiophenes) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) * Thiophenes* / pharmacology Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Thiophenes%2Fpharmacology%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Thiophenes) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42933202/) ## Substances * Photosensitizing Agents Actions * [ Search in Pu
## Related Clinical Research

- [Cisplatin Hydration State Alters Loading, Release, and Cytotoxicity in Heparin–Pluronic F68 Nanoge](https://medichelpline.com/clinical-feed/pubmed-42837810.md) (DOI: 10.1016/j.bbrc.2026.154682)
- [pH-Responsive Chitosan–Boswellic Acid Nanogels for Sustained Sunitinib Delivery and Lung Tumor Sup](https://medichelpline.com/clinical-feed/pubmed-42713680.md) (DOI: 10.1021/acsami.6c02925)
- [Pollen size shifts after whole genome duplication in autotetraploids](https://medichelpline.com/clinical-feed/biorxiv-17-biased-evolution-of-pollen-size-after-whole-genome-duplication.md)
- [Sex Differences in ICI Survival for Advanced NSCLC: Meta-analysis Findings](https://medichelpline.com/clinical-feed/plos-one-15-sex-difference-in-survival-benefits-of-immune-checkpoint-inhibitors-in-advanced.md)
- [Perioperative ivonescimab ± chemotherapy Yields High MPR in Resectable NSCLC (Phase 2)](https://medichelpline.com/clinical-feed/nature-1-perioperative-ivonescimab-with-or-without-chemotherapy-in-resectable-non-small.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.